| ID | Name | CAS | Data |
Tfus (K) |
| 116-086-8 |
6-Chloro-N,N'-(1,1-dimethylpropyl)-[1,3,5]triazine-2,4-diamine
|
|
5 | 409.20 |
| 116-393-7 |
6-Chloro-N,N'-(1-methylbutyl)-[1,3,5]triazine-2,4-diamine
|
|
5 | 365.13 |
| 118-085-7 |
2,4,6(1H,3H,5H)-Pyrimidinetrione, 1,3,5-trimethyl-5-phenyl-
|
|
5 | 395.35 |
| 118-733-7 |
Barbituric acid, 5-(1-cyclohexen-1-yl)-5-ethyl-1,3-dimethyl-
|
891-90-7 |
5 | 361.22 |
| 119-363-7 |
5H-Dibenz[b,f]azepine-5-carboxamide, 10,11-dihydro-10-hydroxy-
|
29331-92-8 |
5 | 467.85 |
| 119-632-8 |
3,5-Dimethyl-5-(3-oxocyclohex-1-enyl)-hexahydropyrimidin-2,4,6-trione
|
|
5 | 441.76 |
| 120-088-1 |
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-cyclohexen-1-yl)-1-ethyl-3,5-dimethyl-
|
55044-42-3 |
5 | 328.76 |
| 120-569-7 |
6-Chloro-N-sec-butyl-N'-acetyl-1,3,5-triazine-2,4-diamine
|
|
5 | 416.42 |
| 120-972-9 |
4-(5-ETHYLQUINUCLIDINE-2-CARBONYL)-1,2-DIHYDRO-2-OXOQUINOLINE
|
|
5 | 505.93 |
| 121-553-3 |
4-ISOPROPYL-2,3-DIMETHYL-1-PHENYL-3-PYRAZOLIN-5-ONE
|
|
5 | 372.88 |
| 122-413-7 |
P-chlorobenzene sulfonic acid, 3-chloro-2,6-dimethoxyphenyl ester
|
18092-96-1 |
5 | 389.24 |
| 122-532-5 |
6-Chloro-N,N'-(1,2-dimethylpropyl)-[1,3,5]triazine-2,4-diamine
|
|
5 | 395.13 |
| 122-669-4 |
Pregn-5-en-20-one, 3,21-bis[(trimethylsilyl)oxy]-, (3.beta.)-
|
|
5 | 408.84 |
| 122-829-6 |
2,4,6(1H,3H,5H)-Pyrimidinetrione, 1,3-dimethyl-5-(2-methylpropyl)-5-(2-propenyl)-
|
55045-04-0 |
5 | 322.85 |
| 122-995-2 |
2,4-bis(1,3-dimethylbutyl-amino)-6-chloro-s-triazine
|
|
5 | 382.72 |
| 123-506-3 |
17«beta»-Estradiol, 3,17-di(dimethyl-tert-butylsilyl)ether
|
57711-41-8 |
5 | 391.49 |
| 10-422-1 |
7-Chloro-N-(3-[(diethylamino)methyl]-4-[(trimethylsilyl)oxy]phenyl)-N-(trimethylsilyl)quinolin-4-amine
|
|
4 | 352.35 |
| 12-585-9 |
O-methyl o,o-bis(2,4,5-trichlorophenyl) thiophosphate
|
56201-37-7 |
4 | 381.78 |
| 13-841-3 |
9H-purine, 2-amino-6-methyl-9-beta-d-ribofuranosyl-
|
|
4 | 485.56 |
| 14-075-3 |
9H-purine-6(1h)-thione, 1-methyl-9-beta-d-ribofuranosyl-
|
|
4 | 508.55 |
| 14-894-4 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-17keto,4«alpha»-ol, monoTMS
|
|
4 | 401.83 |
| 14-962-8 |
1,1,1,5,5,5-Hexafluoroacetylacetone iron(III) salt
|
17786-67-3 |
4 | 447.27 |
| 15-122-9 |
3-«alpha»,4-«xi»,7-«beta»-Trihydroxy-5-«beta»-cholic acid, methyl ester, TMS
|
|
4 | 372.93 |
| 15-718-8 |
5-«alpha»-Cholanoic acid, 3-«alpha»-12-«beta»-dihydroxy, methyl ester, TMS
|
|
4 | 365.70 |
| 15-730-4 |
3-Thiophenamine, tetrahydro-N-methyl-N-nitroso-, 1,1-dioxide
|
|
4 | 383.22 |
| 15-885-3 |
7-Oxo-3«alpha»-hydroxy-5«beta»-cholanic acid, methyl ester, TMS
|
|
4 | 407.77 |
| 16-602-5 |
3-«alpha»,6-«alpha»-Dihydroxy-5-«beta»-cholanoic acid, MeTMS
|
|
4 | 379.34 |
| 16-851-9 |
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-1,3-dimethyl-5-(1-methylbutyl)-
|
28239-47-6 |
4 | 320.79 |
| 16-934-7 |
5«beta»-cholanoate,3«alpha»,7«alpha»-dihydroxy, methyl ester-trimethylsilyl ether
|
|
4 | 382.39 |
| 17-776-2 |
5«beta»-Pregnane-3«alpha»,20«alpha»-diol, (20-O)-TBDMSi
|
|
4 | 420.63 |
| 17-810-3 |
17-«beta»-Hydroxy-17-«alpha»-methyl-5-«beta»-androstan-3-one, 17-TMS
|
|
4 | 402.79 |
| 18-160-4 |
Butanedioic acid, 2,3-dihydroxy- (2R,3R)-, potassium sodium salt, hydrate (1:1:1:4)
|
6381-59-5 |
4 | 601.67 |
| 18-320-6 |
Nickel,bis(1,1,1-trifluoro-2,4-pentanedionato-O,O')-
|
14324-83-5 |
4 | 488.14 |
| 20-651-6 |
Androstan-17-one, 3-[(trimethylsilyl)oxy]-, (3«alpha»,5«alpha»)-
|
7337-91-9 |
4 | 394.27 |
| 22-284-2 |
3«alpha»,7«alpha»-Dihydroxy-5«beta»-cholestanoic acid, MeTMS
|
|
4 | 382.39 |
| 22-537-1 |
3«alpha»,4«beta»-dihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl-ether derivative
|
|
4 | 373.28 |
| 22-711-7 |
Androst-5-en-17-one, 3-[(trimethylsilyl)oxy]-, (3«beta»)-
|
3747-91-9 |
4 | 393.37 |
| 22-837-8 |
Androstan-17-one, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-, (3«beta»,5«alpha»)-
|
57711-44-1 |
4 | 405.34 |
| 23-353-4 |
6-Chloro-N,N'-(cyclopentyl)-[1,3,5]triazine-2,4-diamine
|
|
4 | 435.28 |
| 23-363-3 |
21-Hydroxypregn-4-en-3,20-dione, 20,21-methylboronate
|
|
4 | 406.43 |
| 23-577-6 |
5«alpha»-Androstan-17-one, 3«alpha»,11«beta»-bis(trimethylsiloxy)-
|
17562-92-4 |
4 | 379.74 |
| 23-731-4 |
5-Pregnen-3«beta»-ol-20-one, tert-butyldimethylsilyl ether
|
|
4 | 400.90 |
| 23-873-7 |
Androstan-17-one, 3-[(trimethylsilyl)oxy]-, (3«alpha»,5«beta»)-
|
4867-14-5 |
4 | 394.27 |
| 24-406-4 |
1-Alpha-2-methyl-8-methoxy-6,7-methylenedioxy-1-(6,7-dimethoxy-3-phthalidyl)-1,2,3,4-tetrahydroisoquinoline
|
10421-76-8 |
4 | 407.52 |
| 25-777-2 |
N-tert-Butyl-6-chlor-[1,3,5]triazin-2,4-diamine
|
|
4 | 478.59 |
| 26-843-7 |
20«beta»,21-Dihydroxypregn-4-en-3-one, 20,21-bis-TMS
|
|
4 | 375.66 |
| 27-640-1 |
Silane, dimethyl(trans-3,7-dimethyl-2,6-octadien-1-yloxy)isohexyloxy-
|
|
4 | 204.49 |
| 27-739-2 |
1-«beta»,3-«alpha»,7-«beta»-Trihydroxy-5-«beta»-cholic acid, methyl ester, TMS
|
|
4 | 375.19 |
| 28-354-8 |
3«beta»-Hydroxy-7«alpha»-methoxycholanic acid, methyl ester, TMS
|
|
4 | 382.29 |
| 29-039-7 |
3«beta»,4«beta»-dihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl-ether derivative
|
|
4 | 373.28 |
| 30-482-3 |
3-«beta»-Hydroxy-D-homo-5-androsten-17-one, TMS
|
|
4 | 378.72 |
| 31-293-2 |
3«alpha»,4«beta», 7«alpha»-trihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl-ether derivative
|
|
4 | 372.93 |
| 31-901-6 |
5-«alpha»-Pregnane-3-«beta»,17-«alpha»,20-«alpha»-triol, methylboronate
|
|
4 | 433.38 |
| 31-938-6 |
Phosphorothioic acid, O-(1,6-dihydro-6-oxo-1-phenyl-3-pyridazinyl) O,O-diethyl ester
|
119-12-0 |
4 | 306.70 |
| 32-154-5 |
11B-Hydroxyandrosterone (5A-Androstan-3A,11B-diol-17-one), TMS
|
|
4 | 381.05 |
| 32-486-7 |
4-Androsten-17«alpha»-ol-3-one (epitestosterone), MO-TMS
|
|
4 | 368.05 |
| 33-052-7 |
21-Hydroxypregn-4-en-3,20-dione, bis-MO-21-TMS
|
|
4 | 376.38 |
| 33-499-2 |
O-(2,4,5-trichlorophenyl) n,n,n',n'-tetramethyldiamidothiophosphate
|
|
4 | 380.83 |
| 35-066-0 |
3-«beta»,12-«alpha»-Dihydroxy-5-«alpha»-cholanoic acid, MeTMS
|
|
4 | 365.70 |
| 35-475-6 |
5-«alpha»-Pregnane-17-«alpha»,20-«beta»-diol, bis-TMS
|
|
4 | 375.52 |
| 35-516-0 |
3«beta»-Hydroxy-7«beta»-methoxycholanic acid, methyl ester, TMS
|
|
4 | 382.29 |
| 35-705-0 |
5-«beta»-Cholanoic acid, 3-«alpha»,4-«beta»,7-«alpha»-trihydroxy, methyl ester, TMS
|
|
4 | 372.93 |
| 36-008-3 |
2-Acetamido-2-([(trimethylsilyl)oxy]methyl)propane-1,3-diyl diacetate
|
|
4 | 333.87 |
| 36-739-2 |
17«alpha»-Methyl-17«beta»-hydroxy-1,4-androstadien-3-one, trimethylsilyl deriv.
|
41235-52-3 |
4 | 399.71 |
| 37-043-3 |
2«alpha»,3«alpha»-cyclopropane-5«alpha»-androstan-17keto,4«alpha»-ol, monoTBDMS
|
|
4 | 418.06 |
| 37-814-7 |
Cholan-24-oic acid, 3,12-bis[(trimethylsilyl)oxy]-, methyl ester, (3«alpha»,5«beta»,12«alpha»)-
|
6818-41-3 |
4 | 365.70 |
| 39-541-8 |
17«alpha»,21-Dihydroxypregn-4-en-3,20-dione, bis-MO-21-TMS
|
|
4 | 400.29 |
| 39-674-1 |
3-.beta.,19-Dihydroxy-5-androsten-17-one, MO TMS
|
|
4 | 372.08 |
| 39-938-8 |
3«alpha»,12«beta»-Dihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl ether
|
|
4 | 365.70 |
| 40-031-2 |
3-«beta»,12-«alpha»-Dihydroxy-5-«beta»-cholanoic acid, MeTMS
|
|
4 | 365.70 |
| 40-191-5 |
2-Propanone, [(9-beta-d-ribofuranosyl-9h-purin-6-yl)thio]-
|
|
4 | 433.93 |
| 40-587-6 |
Cinchonan-9-ol, 10,11-dihydro-6'-methoxy-, (8«alpha»,9R)-
|
522-66-7 |
4 | 486.74 |
| 40-908-9 |
3«alpha»-Hydroxy-5«alpha»-pregnan-20-one, O-trimethylsilyl
|
18880-80-3 |
4 | 394.12 |
| 40-944-9 |
Androst-4-en-3-one, 17-[(trimethylsilyl)oxy]-, O-methyloxime, (17«beta»)-
|
56210-83-4 |
4 | 368.05 |
| 40-956-6 |
2-Imidazolidinone, 3-[5-(1,1-dimethylethyl)-1,3,4-thiadiazol-2-yl]-4-hydroxy-1-methyl-
|
55511-98-3 |
4 | 413.05 |
| 41-133-8 |
Trisilane,1,1,1,2,3,3,3-heptamethyl-2-(trimethylsilyl)-
|
|
4 | 284.58 |
| 41-139-2 |
Androstan-17-one, 3-[(trimethylsilyl)oxy]-, (3«beta»,5«beta»)-
|
10426-96-7 |
4 | 394.27 |
| 41-590-1 |
2-keto,3-methyl-5.alpha.-androstan-17.beta.-ol, monoTMS
|
|
4 | 402.36 |
| 42-130-0 |
Androst-4-en-17«alpha»-methyl-17«beta»-ol-3-one, TMS
|
|
4 | 382.73 |
| 42-377-7 |
17«alpha»,21-Dihydroxypregn-4-en-3,20-dione, bis-MO-21-TMS(d9)
|
|
4 | 400.29 |
| 42-392-0 |
4H-1-Benzopyran-4-one, 5-hydroxy-6,7-dimethoxy-2-(4-methoxyphenyl)-
|
19103-54-9 |
4 | 463.92 |
| 42-488-4 |
5-«alpha»-Pregnane-17-«alpha»,20-«alpha»-diol, bis-TMS
|
|
4 | 375.52 |
| 42-492-9 |
5«beta»-Androstane-3,17-dione, mono-TMS, (2-en)
|
|
4 | 383.54 |
| 42-738-6 |
5«beta»-pregnane-3«alpha»,17«alpha»,20«beta»-triol, 17,20-methylboronate
|
|
4 | 449.54 |
| 42-986-1 |
3«alpha»,7«alpha»-dihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
4 | 357.46 |
| 43-021-0 |
Phosphoro diamidic acid, n,n'-bis (2,4-dimethyl phenyl), ethyl ester
|
|
4 | 403.76 |
| 43-060-7 |
7-Chloro-3-methyl-quinoline-8-carboxylic acid, butyl ester
|
|
4 | 306.17 |
| 43-393-8 |
(17«beta»)-2,3-Dimethoxy-17-[(trimethylsilyl)oxy]estra-1(10),2,4-triene
|
|
4 | 391.37 |
| 43-935-6 |
N-tert-Butyl-N'-acetyl-6-chloro-1,3,5-triazine-2,4-diamine
|
|
4 | 468.16 |
| 44-815-8 |
6-Chloro-N,N'-(cyclopropyl)-[1,3,5]triazine-2,4-diamine
|
|
4 | 446.33 |
| 45-215-3 |
6-Chloro-2-methyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide
|
90606-97-6 |
4 | 522.03 |
| 45-216-2 |
3«beta»,16«alpha»-dihydroxy-5-androsten-17-one, TMS
|
|
4 | 393.09 |
| 45-619-5 |
3-«alpha»,12-«alpha»-Dihydroxy-5-«alpha»-cholanoic acid, MeTMS
|
|
4 | 365.70 |
| 45-802-1 |
3«alpha»,12«alpha»-dihydroxy-5«beta»-cholan-24-oic acid, DMESI
|
|
4 | 343.26 |
| 46-390-8 |
3«beta»,4«beta», 7«alpha»-trihydroxy-5«beta»-cholanoic acid, methyl ester-trimethylsilyl-ether derivative
|
|
4 | 372.93 |
| 46-908-3 |
3«alpha»,7«beta»-Dihydroxy-5«beta»-homocholanoic acid, MeTMS
|
|
4 | 386.72 |
| 47-566-2 |
Iron,[(2,3,5,6-«eta»)-bicyclo[2.2.1]hepta-2,5-diene]tricarbonyl-
|
12307-07-2 |
4 | 386.18 |
| 47-657-1 |
3,5-Pyrazolidinedione, 4-butyl-1-(4-hydroxyphenyl)-2-phenyl-
|
|
4 | 439.49 |
| 48-043-1 |
O,O-Dimethyl O-(2,4,5-trichloro)phenyl phosphate
|
3983-45-7 |
4 | 332.25 |
| 48-545-4 |
Carbamic acid, dimethyl-, 2-(formylmethylamino)-5,6-dimethyl-4-pyrimidinyl ester
|
27218-04-8 |
4 | 353.52 |
|
« Previous Results
Next Results »
|